Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease offered by Harvard University
- Private University
3 Campuses- Estd. 1636
Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease at Harvard University Overview
Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease
at Harvard University
This symposium offers an ideal mix of the traditional standard-of-care principles with new, cutting-edge information.
Duration | 3 days |
Total fee | ₹37,372 |
Mode of learning | Online |
Difficulty level | Advanced |
Official Website | Go to Website  |
Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease
Table of content
- Overview
- Highlights
- Course Details
- Curriculum
Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease at Harvard University Highlights
Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease
at Harvard University
- Earn a certificate after completion of the course
Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease at Harvard University Course details
Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease
at Harvard University
What are the course deliverables?
- Apply new knowledge in the management of patients with reflux and swallowing disorders
- Develop treatment strategies based on current evidence and expert-opinion
- Compare and contrast standard-of-care management with cutting-edge treatments
More about this course
- The annual hybrid Minimally Invasive and Novel Therapeutics (MINT) continuing medical education (CME) course, seeks to equip clinicians with advanced technical knowledge of the latest surgical and endoscopic procedures needed to diagnose and treat foregut disease utilizing novel educational formats such as video-based learning to encourage technique transfer
- We further hope to foster ongoing collaboration between gastroenterologists, surgeons, advanced practice providers, nurses, and dietitians to optimize the multidisciplinary care of patients with foregut digestive disease.
- This is an accredited, livestreamed and in-person course offered by Massachusetts General Hospital. This course is targeted to Specialty Physicians, Nurses , Nurse Practitioners , Physician Assistants , Residents, Nutritionists, and Dietitians.
- Select the Take Course button to view additional information on the course registration page.
Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease at Harvard University Curriculum
Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease
at Harvard University
Medicine, Diseases, Healthcare
Other courses offered by Harvard University
4 years
View Other 624 Courses
Study in USAUniversities in USAUniversities in CambridgeHarvard UniversityMinimally Invasive and Novel Therapeutics (MINT) in Foregut DiseaseMinimally Invasive and Novel Therapeutics (MINT) in Foregut Disease at Harvard University Popular & recent articles
Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease
at Harvard University
Raushan Kumar · Sep 11, 2025
Aishwarya Bhatnagar · Sep 19, 2025
Aishwarya Bhatnagar · Sep 8, 2025
43 views
Priya Garg · Sep 27, 2025
6.9L views · 1 comment
View more articles
Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease at Harvard University Contact Information
Minimally Invasive and Novel Therapeutics (MINT) in Foregut Disease
at Harvard University
Address
1350 Massachusetts Ave, Cambridge, Massachusetts 02138, USA
Cambridge ( Massachusetts)
Phone
Go to College Website ->
Useful Links
Know more about Harvard University
Know more about Programs
- Medical Courses
- Public Health & Management
- Hospital Management Course
- Perfusion Technology
- Medical Transcription
- Diabetology
- Forensic Medical Science
- Dialysis Technology
- Cardiovascular Technology
- Cath Lab Technology
- BSc Pathology
- BSc Operation Theatre Technology
- MSc Pathology
- BSc in Perfusion Technology
- Nephrology